Literature DB >> 2277361

Granular cell tumors of the vulva.

B Majmudar1, P Z Castellano, R W Wilson, R J Siegel.   

Abstract

Granular cell tumor (GCT), although nearly ubiquitous, is seen infrequently in the vulva. A review of the surgical pathology files from Grady Memorial Hospital, Atlanta, Georgia, from 1983 through 1987 identified eight cases of vulvar GCT. Five of the eight patients had more than one skin and soft tissue lesion. Two of the five had biopsy-proven multicentric GCT with a unique clinical course. One of the patients was a 32-year-old woman with multiple vulvar, lingual, laryngeal, bronchial and pulmonary GCT, necessitating multiple excisions and ultimately pneumonectomy. The second patient had multiple GCTs in the vulva and inguinal area and finally in both lungs, resulting in her death at age 39. No dependable microscopic features could be identified to distinguish benign GCT from its more aggressive variant. However, Feulgen DNA histomorphometry demonstrated aneuploidy in the patient with apparent lung metastases, whereas the tumors from patients with a benign course as well as from the patient with multiorgan involvement were diploid. In three of five patients who could be interviewed there was a history of soft tissue tumors in members of the family. The multifocal nature and possible familial component of GCT need to be explored further.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2277361

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  2 in total

1.  Case report of granular cell tumor of the vulva and review of current literature.

Authors:  S C Hong; Y K Lim; S H Chew; Y N Chia; K L Yam
Journal:  Gynecol Oncol Case Rep       Date:  2012-11-07

2.  Prognostic factors for recurrence and survival in uncommon variants of vulvar cancer.

Authors:  Ignacio Zapardiel; Myriam Gracia; Javier Díez; Alessandro Buda; Maria C Noya; Pierandrea De Iaco; Pedro Vieira-Baptista; Sara Iacoponi
Journal:  Arch Gynecol Obstet       Date:  2020-10-16       Impact factor: 2.344

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.